YUNIZA; MELANI; RATNA MAILA DEWI ANGGRAINI; YENNY DIAN ANDAYANI. Efficacy and Safety of IL-5 Pathway-Targeting Biologics (Mepolizumab, Reslizumab, Benralizumab) in the Management of Hypereosinophilic Syndromes: A Systematic Review and Meta-Analysis. Open Access Indonesian Journal of Medical Reviews, v. 5, n. 5, p. 1481-1500, 11 Jul. 2025.